Search

everythinglearnresearchcommunity

for

Search:↓

The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.

A 30-year-old man with rare skin conditions improved with antibiotics and surgery, hinting at a link to rosacea.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Efalizumab can cause unexpected excessive hair growth.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

A woman in Pakistan was diagnosed with Lupus Vasculitis and treated successfully.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.

Careful diagnosis and management of MCTD are crucial due to potential severe complications.

Cancer treatments often cause skin, nail, and hair problems.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Rash in SLE patients indicates more severe disease.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

The man was diagnosed with lupus and improved with treatment.

Alopecia can be caused by multicentric reticulohistiocytosis.

Skin rashes can help diagnose COVID-19 early.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.